NousCom receives $49M to trial off-the-shelf cancer vaccine
Author: Prasanth | Date: March 16, 2025
Cancer vaccine startup NousCom has raised €42 million ($49 million).
Read More
Author: Prasanth | Date: March 16, 2025
Cancer vaccine startup NousCom has raised €42 million ($49 million).
Read More
Author: Prasanth | Date: July 7, 2025
Cancer vaccine startup NousCom has raised €42 million ($49 million).
Read More